Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000082

Chief Medical Officer sold 11,914 shares at an average $37.99 ($452,601)

  • Chief Medical Officer acquired 11,914 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-07-09 Exercise or conversion : show line 1 in the form 10b5-1 +11,914 $25.01 $297,969 73,185 D
2025-07-09 Sale : show line 2 in the form 10b5-1 −11,067 $37.93 $419,771 62,118 D
2025-07-09 Sale : show line 3 in the form 10b5-1 −847 $38.76 $32,830 61,271 D
Open-market sales · 11,914 sh · avg $37.99 · $452,601

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-09 Exercise or conversion : show line 4 in the form 10b5-1 Stock options (right to buy) −11,914 32,086 D
Loading xslF345X05/wk-form4_1752267546.xml…